Ignite Creation Date:
2024-05-06 @ 12:27 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03769948
Status:
UNKNOWN
Last Update Posted:
2020-09-18
First Post:
2018-12-06
Brief Title:
Clinical Decision Support Algorithm to Predict Diabetic Retinopathy
Sponsor:
Oklahoma State University Center for Health Sciences
Organization:
Oklahoma State University Center for Health Sciences
Study Overview
Official Title:
Validating a Clinical Decision Support Algorithm Developed With Demographic Co-morbidity and Lab Data to Diagnose Stage Prevent and Monitor a Patients Diabetic Retinopathy
Status:
UNKNOWN
Status Verified Date:
2020-09
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Diabetic retinopathy DR a complication of diabetes is a leading cause of blindness among working-aged adults globally In its early stages DR is symptomless and can only be detected by an annual eye exam Once the disease has progressed to the point where vision loss has occurred the damage is irreversible Consequently early detection is quintessential in treating DR Two barriers to early detection are poor patient compliance with the annual exam and lack of access to specialists in rural areas This research is focused on developing and validating new cost-effective predictive technologies that can improve early screening of DR Our overall objective is to develop and implement an entire suite of tools to detect diabetes complications in order to augment care for underserved rural populations in the US and internationally
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None